"A digital health company that signs up patients for clinical trials raises $11 million"

Our latest round of funding will allow us to expand on our work to transform the way patients connect to medical research. covered the story: 

"A digital healthcare company that says it has a new way to sign up patients for clinical trials online has raised $11 million in new funding. Antidote Technologies Ltd has raised the new funding from a group led by Merck Global Health Innovation Fund that includes existing investors Smedvig Capital and Octopus Ventures. The company, which changed its name to Antidote from TrialReach Ltd a year ago, develops and markets a trio of digital products for the clinical trials market." Read more.